Air Methods files chapter 11; $155 million DIP and $335 million exit financing
We are advising an ad hoc group of first-lien lenders and unsecured noteholders in connection with Air Methods’ chapter 11 restructuring
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
IDEAYA Biosciences $143.8 million equity offering
The common stock is listed on the Nasdaq Global Select Market
Vinci Partners $100 million placement and strategic partnership with Ares
We advised Vinci Partners on the private placement
UCT acquisition of HIS Innovations Group
We advised UCT on the acquisition
Semtech $250 million convertible senior notes offering
We advised Semtech on its private placement of 4% convertible senior notes due 2028
J.M. Smucker $3.5 billion notes offering
The investment-grade debt offering comprises four tranches of notes
RTX $10 billion accelerated share repurchase
The company is repurchasing shares of stock
indie Semiconductor warrant exchange offer
A total of 24,658,461 warrants were tendered for stock
Orbital Infrastructure DIP financing and section 363 purchase of Front Line Power
We advised the prepetition secured lenders and DIP lenders